Phathom Pharmaceuticals Q3 Revenue Climbs 71.1% to $84.7 Million

Your call?🐂 Bullish🐻 Bearish

Non-GAAP earnings per share were $0.04, beating estimates by $0.01, while revenue missed by $120,000. Phathom reaffirmed its 2026 net revenue outlook of $310 million to $325 million.